Let's review the charts and indicators for some price targets. We last reviewed the charts of AZN on June 24 and wrote that, "I have no idea what AZN has in the pipeline but announcements of new blockbuster drugs are game changers. Traders could go long AZN around $54 risking a close below $50. Add on strength above $58. $84 is our longer-term price target."
More from Investing
RL is among many companies who are trying to recreate themselves.
The pockets of strong movement are very narrow right now.
With a month to go for these portfolios, the Active version is outperforming the Passive one, though both are crushing their Russell kindred.